ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: "Sunesis Pharmaceuticals, Inc." (SNSS) Report Updated: Feb 20, 2017 | Print This Page

Get more stock ratings by Louis Navellier

"Sunesis Pharmaceuticals, Inc." (SNSS)

Rating: Hold Volatility: Moderate
Total Grade: C Industry: Biotechnology
Competitors: CLCD,EXEL,PIP,ARRY

Stock Analysis

Rating: Monthly View

A
B
C
D
F
February March April May June July August September October November December January

Rating: Weekly View

This Week: C down no change
Last Week: C same upgrade
Two Weeks Ago: D up downgrade
service keys

"Sunesis Pharmaceuticals, Inc."© quotemedia

Company Profile